Definitive Contract 75F40120C00167
Award Date 9/14/20
Potential Completion Date 9/14/23
Potential Value $596K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
8(a) Sole Source
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $873,297.87 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Bracane Company, a woman-owned small business based in Plano, Texas. The contract is for clinical operations and clinical trial site monitoring services. Bracane Company has multiple small business certifications, including Economically Disadvantaged Women-Owned Small Business (EDWOSB) and 8(a) Program Participant, and has a history of delivering specialized healthcare services to federal...
- This is a $301,204.40 firm-fixed-price delivery order awarded by the Food and Drug Administration (FDA) to Bracane Company, a small, woman-owned business certified as an Economically Disadvantaged Women-Owned Small Business (EDWOSB) and 8(a) Program Participant. The delivery order was issued under Bracane's existing Indefinite Delivery Contract (IDC) with the FDA, titled "RECALL & AUDIT IDIQ CONTRACT," which has a $4,000,000 ceiling value and runs through September 16, 2029. This...
- This federal contract award, with a ceiling value of $301,204.40, was issued by the Food and Drug Administration (FDA) to Bracane Company, a small, woman-owned business certified as an Economically Disadvantaged Women-Owned Small Business (EDWOSB) and 8(a) Program Participant by the Small Business Administration (SBA). The contract is a delivery order under Bracane Company's Indefinite Delivery Contract (IDC) with the FDA, titled "RECALL & AUDIT IDIQ CONTRACT," which has a...
- The U.S. Food and Drug Administration (FDA) awarded a $200,000 delivery order contract to Realm Research LLC, a minority-owned small disadvantaged woman-owned small business, to monitor the conduct and progress of extramural FDA-funded research studies in human subjects overseen by the Center for Drug Evaluation and Research (CDER). This contract is part of a larger $1.1 million indefinite delivery contract awarded to Realm Research in 2023 to provide broader scientific and clinical support...
- The Food and Drug Administration (FDA) awarded an 8(a) direct contract to Aneon Brillient, LLC on August 2, 2024, for professional services supporting the Center for Drug Evaluation and Research (CDER). The definitive labor-hour contract has a 12-month base period with a 9-month option and a total ceiling value of approximately $4.3 million. Work will be performed in Calverton, Maryland, with an ultimate completion date of May 31, 2026. This award was not set aside for small businesses but...
- The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a purchase order contract to Government Solutions Group, LLC, a SBA certified 8(a) program participant, minority-owned, and Native American-owned small business. The contract, awarded on March 3, 2023, provides CDRH Strategic Priorities Support services to be performed in Silver Spring, MD with a potential value of $216,743.95 and a completion date of September 30, 2023. The contract is a labor hours...
- The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $308,625.00 purchase order contract to NMD Group, LLC, a woman-owned small business, to support the FDA's planning for real-world data and real-world evidence related to COVID-19. The contract has a completion date of September 7, 2021 and is structured as a labor hours contract. This contract award appears to be part of the FDA's efforts to accelerate planning and utilization of real-world data and...
- This is a firm fixed price delivery order issued by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Spaulding Clinical Research, LLC, a self-certified small disadvantaged business. The $6,561,386.54 contract is for a range of clinical and laboratory applied regulatory science services that support the FDA's regulatory science programs and decision-making across product lifecycles. Services include conducting clinical...
- This federal contract was awarded by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Brillient Corporation, a minority-owned, for-profit Subchapter S Corporation. The objective of the contract is to acquire interdisciplinary scientific services to support the FDA. The contract, a Blanket Purchase Agreement (BPA) call, has a ceiling value of $1,374,476.15 and a period of performance through August 23, 2024. The contract...
- This federal contract award, with ID HHSF223201610616A, was issued by the Food and Drug Administration (FDA) to Lake Research Partners, Inc., a small disadvantaged woman-owned business. The contract, with a ceiling value of $287,814.40, is for MCM (Medical Countermeasures) studies to enhance FDA communications. The contract has a firm fixed-price structure and a completion date of February 28, 2019. The place of performance is Washington, DC. This contract award is not associated with a larger...